Do You Believe in the Growth Prospects of Edwards Lifesciences Corporation (EW)?
Wedgewood Partners, an investment management company, released its fourth-quarter 2024 investor letter. A copy of the letter can be downloaded here.
Edwards Lifesciences Corp (EW)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Bourgeon Capital John Zaro | 3,149 | $233,121 | 0.04% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $85.74 | 580 | Officer, Director | 3,268 | 2024-05-06 | Filing | |
| $112.23 | 1,500 | Director | 63,811 | 2021-11-24 | Filing | |
| $90.10 | 3,000 | Director | 9,042 | 2017-02-03 | Filing | |
| $83.33 | 3,942 | Officer | 3,942 | 2016-11-30 | Filing | |
| $83.47 | 8,928 | Officer | 43,690 | 2016-11-30 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $68.76 | 500 | Officer | 23,189 | 2025-01-16 | Filing | |
| $68.75 | 5,000 | Officer | 46,936 | 2025-01-16 | Filing | |
| $74.08 | 2,500 | Officer | 23,189 | 2024-12-16 | Filing | |
| $71.68 | 11,250 | Officer | 30,561 | 2024-12-09 | Filing | |
| $71.75 | 5,000 | Officer | 46,936 | 2024-12-09 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 52,362,913 | $3,992,672,117 | 0.08% | |
| 2. | 52,172,777 | $3,978,174,250 | 0.1% | |
| 3. | 26,955,650 | $2,055,368,313 | 0.09% | |
| 4. | 19,088,643 | $1,455,509,029 | 0.56% | |
| 5. | 18,181,420 | $1,386,333,279 | 1.94% |
News See All
12 Cheap Healthcare Stocks to Buy Heading into 2025
Investing in healthcare equities is typically seen as protective during recessionary times.
Jim Cramer Recently Discussed These 7 Stocks
Jim Cramer, host of Mad Money, recently addressed how investors can sometimes lose sight of the broader market perspective.
Edwards Lifesciences Corporation (EW) Fell Due to Missed Earnings Expectations and Weak Guidance
Baron Funds, an investment management company, released its “Baron Health Care Fund” third quarter 2024 investor letter. A copy of the letter can be downloaded here.
Edwards Lifesciences Corporation (NYSE:EW) Q3 2024 Earnings Call Transcript
Edwards Lifesciences Corporation (NYSE:EW) Q3 2024 Earnings Call Transcript October 24, 2024Edwards Lifesciences Corporation beats earnings expectations.
Here’s Why Edwards Lifesciences Corporation (EW) Detracted
Wedgewood Partners, an investment management company, released its third-quarter 2024 investor letter. A copy of the letter can be downloaded here.
Artisan Mid Cap Fund Sold Edwards Lifesciences Corporation (EW) as it Failed to Meet Growth Expectations
Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” third quarter 2024 investor letter. A copy of the letter can be downloaded here.
Edwards Lifesciences Corporation (NYSE:EW) Q2 2024 Earnings Call Transcript
Operator: Greetings, and welcome to the Edwards Lifesciences Second Quarter 2024 Results. At this time, all participants are in a listen-only mode.
Is Edwards Lifesciences Corp (NYSE:EW) the Best Medical Stock to Buy in 2024?
We recently published a list of the 10 Best of Breed Stocks to Buy For The Third Quarter of 2024 According to Bank of America. Since Edwards Lifesciences Corp (NYSE:EW) ranks 5th on the list, it deserves...
10 Best of Breed Stocks to Buy For The Third Quarter of 2024 According to Bank of America
Analysts at BofA Securities recently published a list of "best of breed" stocks for the third quarter of 2024, which they believe are the top choices for investors on the back of their high quality, liquidity...
Billionaire Hedge Funds
